Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02121977 · ClinicalTrials.gov registry record · Phase 4
Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse
A Phase 4 study, sponsored by ASTORA Women's Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 285
- Enrollment target
NCT02121977: Clinical Trial Phase 4 study, sponsored by ASTORA Women's Health.
NCT02121977 is a Phase 4 study that was terminated before completion, run by ASTORA Women's Health. The registered enrollment target is 285 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02121977, a Phase 4 study, was terminated before completion, sponsored by ASTORA Women's Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 285 participants
- Enrollment target
Study Summary
The aim of this study is to further evaluate the safety and efficacy of the Elevate® Anterior and Apical Prolapse Repair System for repair of anterior/apical pelvic organ prolapse in a controlled, post-market cohort study.
Interventions
- PROCEDURE Native Tissue Repair for pelvic organ prolapse
- DEVICE Elevate Anterior and Apical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-04 |
| Phase | Phase 4 |
Why NCT02121977 stopped before completion
NCT02121977 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 2 interventions - of which Native Tissue Repair for pelvic organ prolapse is the first listed.
NCT02121977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02121977 about?
NCT02121977 is a clinical study titled "Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse". The aim of this study is to further evaluate the safety and efficacy of the Elevate® Anterior and Apical Prolapse Repair System for repair of anterior/apical pelvic organ prolapse in a controlled, post-market cohort study.
What is the current status of trial NCT02121977?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 285 participants. The study started on 2014-04. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02121977?
The interventions under investigation include: Native Tissue Repair for pelvic organ prolapse (PROCEDURE), Elevate Anterior and Apical (DEVICE).
Who is sponsoring clinical trial NCT02121977?
This trial is sponsored by ASTORA Women's Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02121977's enrollment target sits among peer trials
285 302nd of 2000 higher than 1,699 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03412877 · 285 participants · Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- NCT04537936 · 285 participants · NA
Psychotherapy Intervention for Latinos With Adv Cancer
- NCT04965675 · 285 participants · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- NCT05320835 · 285 participants · NA
A Setting Focus Overdose Prevention Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia